SMAD2 and myelodysplastic syndrome: Subsequently, the cause of the overactivation of SMAD2/3 in MDS hematopoietic cells was investigated, and it was shown that the levels of SMAD7 were markedly reduced in MDS marrow cluster of differentiation 34+ (CD34+) cells compared to normal healthy controls [15].